See other bills
under the
same topic
PRINTER'S NO. 3177
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
762
Session of
2018
INTRODUCED BY FREEMAN, HENNESSEY, BAKER, BURNS, READSHAW,
DeLUCA, NEILSON, DRISCOLL, DONATUCCI, WARD, RYAN, DiGIROLAMO,
THOMAS, MATZIE, SONNEY, DUSH, MILLARD, MEHAFFIE, SCHLOSSBERG,
LONGIETTI, PASHINSKI, KAVULICH, DEASY, PICKETT, MACKENZIE,
COX, O'NEILL, J. McNEILL, STAATS, DOWLING, SAINATO,
YOUNGBLOOD, EVERETT, CAUSER, VITALI, CALTAGIRONE, MURT,
WARREN, SCHWEYER, OBERLANDER, MARSICO, HILL-EVANS, WATSON,
KINSEY, BRADFORD, GILLEN AND SCHLEGEL CULVER, MARCH 15, 2018
INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35,
MARCH 15, 2018
A RESOLUTION
Recognizing the month of May 2018 as "Bladder Cancer Awareness
Month" in Pennsylvania.
WHEREAS, In 2018, an estimated 4,240 individuals will be
diagnosed with bladder cancer in this Commonwealth; and
WHEREAS, More than 500,000 individuals throughout the United
States live with bladder cancer; and
WHEREAS, Bladder cancer affects individuals of all ages and
backgrounds and is among the top 10 cancers with the highest
incidence rates in the United States, with Pennsylvania ranked
sixth in new cases of bladder cancer diagnosed as of 2018; and
WHEREAS, Bladder cancer is known as one of the most expensive
cancers to treat on a per-patient basis, with a recurrence rate
of approximately 50% to 80%, and requires lifelong surveillance;
and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
WHEREAS, While bladder cancer symptoms, such as blood in
urine, are easily recognized, many people are unaware of the
threat of bladder cancer; and
WHEREAS, If diagnosed early, bladder cancer is treatable; and
WHEREAS, If diagnosis and treatment are delayed, the life
expectancy of an individual with bladder cancer decreases; and
WHEREAS, Military veterans are more likely than nonveterans
to be diagnosed with bladder cancer; and
WHEREAS, Women are often diagnosed at a later stage of
bladder cancer; and
WHEREAS, Even when diagnosed at the same stage as men, women
have worse survival rates; and
WHEREAS, The quality of life for an individual with bladder
cancer depends on diagnostic and treatment developments and
research advancements; and
WHEREAS, There have been no new treatments developed for
bladder cancer in more than 20 years; and
WHEREAS, A lack of awareness about bladder cancer within the
medical community and general public has limited research
advancements for the disease; and
WHEREAS, Increased awareness promotes early diagnosis and
higher survival rates; and
WHEREAS, Increased awareness bolsters public support for
medical treatment; and
WHEREAS, Increased awareness generates greater funding for
innovative research and development relating to diagnostic tools
and treatment options; and
WHEREAS, Traditionally on the first Saturday in May,
survivors, caregivers and loved ones walk together throughout
the United States to raise awareness for bladder cancer; and
20180HR0762PN3177 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
WHEREAS, The Bladder Cancer Advocacy Network and its
community of patients, caregivers and specialists foster hope
and support, fund and conduct research and promote public
awareness of bladder cancer; therefore be it
RESOLVED, That the House of Representatives recognize the
month of May 2018 as "Bladder Cancer Awareness Month" in
Pennsylvania; and be it further
RESOLVED, That the House of Representatives support the goals
and ideals of "Bladder Cancer Awareness Month"; and be it
further
RESOLVED, That the House of Representatives call on the
residents of this Commonwealth to promote awareness of bladder
cancer, foster an understanding of the impact of the disease,
take an active role in the fight to end bladder cancer and
observe "Bladder Cancer Awareness Month" with appropriate
ceremonies and activities.
20180HR0762PN3177 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16